Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists

Wenham, 2020, Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak, Lancet, 395, 846, 10.1016/S0140-6736(20)30526-2 Liang, 2020, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, 21, 335, 10.1016/S1470-2045(20)30096-6 Naspro, 2020, Urology in the time of corona, Nat Rev Urol, 17, 251, 10.1038/s41585-020-0312-1 Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.027. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 He F, Deng Y, Li W. Coronavirus disease 2019 (COVID-19): what we know? J Med Virol. In press. https://doi.org/10.1002/jmv.25766. Cheng, 2007, Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection, Clin Microbiol Rev, 20, 660, 10.1128/CMR.00023-07 Chan, 2015, Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease, Clin Microbiol Rev, 28, 465, 10.1128/CMR.00102-14 Li, 2016, Structure, function, and evolution of coronavirus spike proteins, Annu Rev Virol, 3, 237, 10.1146/annurev-virology-110615-042301 Li, 2005, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309, 1864, 10.1126/science.1116480 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 10.1016/j.cell.2020.02.052 Li, 2020, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, 382, 1199, 10.1056/NEJMoa2001316 Van Doremalen, 2020, Aerosl and surface stability of HCov-19 (SARS-CoV-2) compared to SARS-CoV-2, N Engl J Med, 382, 1564, 10.1056/NEJMc2004973 CDC. C.D.C. resource on SARS-CoV-2. https://www.cdc.gov/sars/about/faq.html. Zhao S, Chen H. Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Quant Biol. In press. https://doi.org/10.1007/s40484-020-0199-0. CBS News. www.cbsnews.com/news/coronavirus-update-china-lift-lockdown-wuhan-april-8-epicenter-quarantine/. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention, 2020, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, Zhonghua Liu Xing Bing Xue Za Zhi, 41, 145 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Livingston, 2020, Coronavirus disease 2019 (COVID-19) in Italy, JAMA, 323, 1335, 10.1001/jama.2020.4344 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5 Cai, 2020, Sex difference and smoking predisposition in patients with COVID-19, Lancet Respir Med, 8, e20, 10.1016/S2213-2600(20)30117-X Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Zou, 2020, Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front Med, 14, 185, 10.1007/s11684-020-0754-0 Naicker, 2020, The novel coronavirus 2019 epidemic and kidneys, Kidney Int, 97, 824, 10.1016/j.kint.2020.03.001 Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv. In press. https://doi.org/10.1101/2020.02.18.20023242. Wu, 2020, The SARS-CoV-2 outbreak: what we know, Int J Infect Dis., 94, 44, 10.1016/j.ijid.2020.03.004 Zhang, 2020, Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerg Microbes Infect, 9, 386, 10.1080/22221751.2020.1729071 Vardavas, 2020, COVID-19 and smoking: a systematic review of the evidence, Tob Induc Dis, 18, 20, 10.18332/tid/119324 Foerster, 2018, Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and meta-analysis, JAMA Oncol, 4, 953, 10.1001/jamaoncol.2018.1071 Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 8, e21, 10.1016/S2213-2600(20)30116-8 Sutcliffe, 2016, Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection, Int J Cancer, 138, 2221, 10.1002/ijc.29966 Xiao, 2020, Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology, 158, 10.1053/j.gastro.2020.02.055 Ling, 2020, Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients, Chin Med J (Engl), 133, 1039, 10.1097/CM9.0000000000000774 Fossati, 2017, Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely?, Urol Oncol, 35, 10.1016/j.urolonc.2016.11.010 Loeb, 2016, Immediate versus 131 delayed prostatectomy: nationwide population-based study, Scand J Urol, 50, 246, 10.3109/21681805.2016.1166153 Park, 2014, Interval from prostate biopsy 127 to radical prostatectomy does not affect immediate operative outcomes for open or minimally 128 invasive approach, J Korean Med Sci, 29, 1688, 10.3346/jkms.2014.29.12.1688 Gupta, 2019, Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer, BJU Int, 124, 268, 10.1111/bju.14659 ERUS Guidelines for COVID 19. www.uroweb.org/wp-content/uploads/ERUS-guidelines-for-COVID-def.pdf. Kumar DS, O’Neill SB, Johnston JC, et al. SARS-CoV-2 infection in a 76-year-old man with negative results for nasopharyngeal swabs and possible nosocomial transmission. CMAJ. In press. https://doi.org/10.1503/cmaj.200641. Thomas-Rüddel D, Winning J, Dickmann P, et al. Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. Anaesthesist. In press. https://doi.org/10.1007/s00101-020-00760-3. Wax, 2020, Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients, Can J Anaesth, 67, 568, 10.1007/s12630-020-01591-x WRSE, 2020 Zheng MH, Boni L, Fingerhut A. Minimally invasive surgery and the novel coronavirus outbreak: lessons learned in China and Italy. Ann Surg. In press. https://doi.org/10.1097/SLA.0000000000003924. Kimmig, 2020, Robot assisted surgery during the COVID-19 pandemic, especially for gynecological cancer: a statement of the Society of European Robotic Gynaecological Surgery (SERGS), J Gynecol Oncol, 31, e59, 10.3802/jgo.2020.31.e59 Novara G, Giannarini G, De Nunzio C, Porpiglia F, Ficarra V. Risk of SARS-CoV-2 diffusion when performing minimally invasive surgery during the COVID-19 pandemic. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.015. Sanguineti, 2019, Leukotoxicity after moderately hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate cancer: a secondary analysis from a randomized study, Radiat Oncol, 14, 23, 10.1186/s13014-019-1223-2 Zaorsky NG, Yu JB, McBride SM, et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv Radiat Oncol. In press. https://doi.org/10.1016/j.adro.2020.03.010. Prostate Cancer Foundation, COVID Resource. www.curetoday.com/advocacy/prostate-cancer-foundation/prostate-cancer-foundations-covid19-resources. Mohile, 2009, Management of complications of androgen deprivation therapy in the older man, Crit Rev Oncol Hematol, 70, 235, 10.1016/j.critrevonc.2008.09.004 Farooqi, 2014, Androgen receptor and gene network: micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells, Cancer Cell Int, 14, 34, 10.1186/1475-2867-14-34 Ring, 2002, Influenza vaccination and chemotherapy: a shot in the dark?, Support Care Cancer, 10, 462, 10.1007/s00520-001-0337-9 Boehmer, 2010, Influenza vaccination in patients with cancer: an overview, Oncology (Williston Park)., 24, 1167 Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2020.0980. Schepisi, 2017, Immunotherapy for prostate cancer: where we are headed, Int J Mol Sci, 18, 2627, 10.3390/ijms18122627 Lurie, 2018, The role of telehealth in the medical response to disasters, JAMA Intern Med, 178, 745, 10.1001/jamainternmed.2018.1314 Hollander, 2020, Virtually perfect? Telemedicine for COVID-19, N Engl J Med, 382, 1679, 10.1056/NEJMp2003539 Wikipedia. 2020 Coronavirus pandemic in South Korea. March 29, 2020. https://en.wikipedia.org/wiki/2020_coronavirus_pandemic_in_South_Korea. Coronavirus: why did infections shoot up in South Korea? February 25, 2020. https://www.bbc.com/news/world-asia-51609840. Elflien, 2020 abcNEWS. https://abcnews.go.com/Health/learn-americans-died-coronavirus/story?id=69588942. Thomala, 2020 Statista Research Department, 2020 Begley, 2020 So, 2020 Roser, 2020 Bendix, 2020, Men represent the majority of coronavirus cases so far, Researchers think smoking could play a role KFF, 2020 NYC Health. https://www1.nyc.gov/site/doh/covid/covid-19-data.page. Medscape. Risk factors for death from COVID-19 Identified. March 9, 2020. https://www.medscape.com/viewarticle/926504. Onder, 2020 CEBM. Global COVID-19 case fatality rates. https://www.cebm.net/global-covid-19-case-fatality-rates/. healthline.com. People with diabetes may have high risk. https://www.healthline.com/health-news/people-with-diabetes-risk-healthcare-covid19. Cunningham, 2020 Healio, 2020 The ASCO Post. COVID-19 infection in patients with cancer in China. https://ascopost.com/news/march-2020/covid-19-infection-in-patients-with-cancer-in-china/. Howard, 2020 Pass W. MDedge News, March 31, 2020. COVID-19: extra caution needed for patients with diabetes. https://www.the-hospitalist.org/hospitalist/article/219144/diabetes/covid-19-extra-caution-needed-patients-diabetes. Benyon B. Are patients with cancer at higher risk of COVID-19? https://www.oncnursingnews.com/web-exclusives/are-patients-with-cancer-at-higher-risk-of-covid-19. CDC COVID-19 Response Team, 2020 McCarthy, 2020 Markowski, 2019, PSA doubling time and absolute PSA predict metastasis-free survival in men with biochemically recurrent prostate cancer after radical prostatectomy, Clin Genitourin Cancer, 17, 10.1016/j.clgc.2019.08.002 Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. In press. https://doi.org/10.1016/j.annonc.2020.03.296. Koo JR, Cook AR, Park M, et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. In press. https://doi.org/10.1016/S1473-3099(20)30162-6. Dovey, 2020, Building a prostate cancer lifestyle medicine program